Zhu et al. used CRISPR/Cas9 gene-editing technology to knockout the EGFL6 gene in the ovarian cancer cell line SKOV3 by designing a specific guide RNA targeting its exons. The gene discussed is EGFL6; the disease is ovarian carcinoma.